AC
FLGT icon

Almitas Capital’s Fulgent Genetics FLGT Stock Holding History

Almitas Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15M Hold
104,797
– – 0.52% 45
2026
Q1 		$1.67M Buy
104,797
+86,319
+467% +$1.87M 0.38% 51
2025
Q4 		$485K Sell
18,478
-3,000
-14% -$77.8K 0.11% 80
2025
Q3 		$485K Sell
21,478
-9,582
-31% -$197K 0.11% 58
2025
Q2 		$617K Buy
31,060
+2,342
+8% +$45.6K 0.16% 50
2025
Q1 		$485K Buy
28,718
+12,718
+79% +$217K 0.16% 62
2024
Q4 		$296K Buy
+16,000
New +$312K 0.06% 79

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Almitas Capital's FLGT Position: Q2 2026 in Review

Almitas Capital held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 104,797 shares worth $2.15M. The position accounts for 0.52% of the portfolio, ranked #45.

Almitas Capital first reported a position in FLGT in Q4 2024 and has held it in 7 quarters since. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Almitas Capital held 104,797 shares of Fulgent Genetics worth $2.15M as of Q2 2026.
  • Almitas Capital left its Fulgent Genetics share count unchanged in Q2 2026.
  • Fulgent Genetics made up 0.52% of Almitas Capital's portfolio in Q2 2026, its #45 holding.
  • Almitas Capital first reported a position in Fulgent Genetics in Q4 2024 and has held it in 7 quarters since.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Almitas Capital's 13F filing for Q2 2026, filed 17 Aug 2026.